6
EN
VII. CONTRAINDICATIONS
The LARYVOX
®
PRO HME should be removed if respiratory resistance is too high.
Use in patients with strong exsiccosis (dehydration), or excessive secretion in the lungs and airways, or
strong air leakage flow (exhaled air not flowing through the filter cassette) is not permissible.
Not for use in patients with impaired consciousness and/or in non-independent persons
requiring the help of others, who are not able to remove the LARYVOX
®
PRO HME filter cassette
by themselves in emergency situations.
VIII. INSTRUCTIONS
1. Check whether the packaging and the product are in a faultless condition.
2. Press the speaking button down in order to check whether it is fully functional (➍a). When the
speaking button is released, it immediately returns to the open starting position (➍b).
3. Check the use-by or expiry date. Do not use after this date.
4. Fit ➎ the LARYVOX
®
PRO HME filter cassettes vertically onto the 22-mm connection of the
tracheostomy tube or base plate, exerting gentle pressure.
5. Check the respiratory resistance.
6. For speaking, press the speaking button ➏ down slightly with your finger so as to enable
phonation by means of the closure.
7. When the speaking button is released, it immediately returns to its open breathing position
(starting position) ➐.
8. Remove the LARYVOX
®
PRO HME filter cassettes after a ➑ wearing period of 24
hours at most, or if the filter cassette is contaminated with secretions for instance. To do this,
hold the base plate or the tracheostomy tube in position with two fingers ➒ and remove the
filter cassette by tilting it downward slightly.
IX. SERVICE LIFE
The maximum period of use / wearing period is 24 hours.
The filter must be changed even several times a day if required, for instance if the respiratory resistance
is in danger of increasing due to accumulation of secretions.
X. LEGAL NOTICES
The manufacturer Andreas Fahl Medizintechnik-Vertrieb GmbH will not accept any liability for
damages caused by unauthorised product alterations, by repairs not performed by the
manufacturer or by improper handling, care (cleaning/disinfection) and/or storage of the
products in violation of the provisions of these instructions for use.
Should a serious adverse event occur in connection with this product of Andreas Fahl Medizintechnik-
Vertrieb GmbH, this is to be reported to the manufacturer and the competent authority of the Member
State in which the user and/or patient are domiciled.
Product specifications described herein are subject to change without notice.
LARYVOX
®
is a trademark and brand of Andreas Fahl Medizintechnik-Vertrieb GmbH, Cologne
registered in Germany and the EU member states.
Содержание LARYVOX PRO HME
Страница 1: ...ES PT LARYVOX PRO HME GEBRAUCHSANWEISUNG INSTRUCTIONS FOR USE ...
Страница 2: ...DE EN 1 8 BILDER PICTURES a b a 2 a b 3 4a 4b 5 6 7 9 ...
Страница 53: ......
Страница 54: ......
Страница 55: ......